Liste des publications GINECO - Cancer Ovaire 2009

  • CartaxhyPoster – 4,87 Mo
    L. Gladieff
    Monotherapy versus doublet in resistant ovarian cancer: a randomised phase II gineco trial (cartaxhy)
    ASCO 2009 (article sous presse) – 2009
  • TCGAbstract – 46 ko
    AC. Hardy-Bessard
    Final results of the GCIG phase III study (AGO-OVAR-9, GINECO-TCG, NSGO-OC-0102): Gemcitabine-Paclitaxel-Carboplatin versus Paclitaxel-Carboplatin as First-line Treatment of Ovarian Cancer
    ESGO 2009 (article sous presse) – 2009
  • TCGAbstract – 46 ko
    J. Herrstedt
    A randomized, phase III study (AGO-OVAR-9, GINECO-TCG, NSGO-OC-0102): gemcitabine-paclitaxel-carboplatin (TCG) versus paclitaxel-carboplatin (TC) as firstline treatment of ovarian cancer (OC): survival of FIGO stage I-IIA patients
    ESGO 2009 (article sous presse) – 2009
  • PACAArticle (Anticancer Research)
    B. Weber
    Pegylated liposomal doxorubicin and carboplatin in late-relapsing ovarian cancer: a GINECO group phase II trial.
    Anticancer Research - Novembre 2009 (réf. PubMed : PMID: 19846972 [PubMed - indexed for MEDLINE] - Anticancer Res. 2009 Oct;29(10):4195-200)
  • ElogemArticle (British Journal of Cancer) ou Article (PubMed Central)
    I. Ray-Coquard
    Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group
    British Journal of Cancer – Février 2009 (réf. PubMed : PMID: 19190632 [PubMed - indexed for MEDLINE] - PMCID: PMC2653739 -
    Br J Cancer. 2009 Feb 24;100(4):601-7. doi: 10.1038/sj.bjc.6604878. Epub 2009 Feb 3.)
Haut de page
Modifié le 30-08-2016 16:18:57